Support for the aerosol development of bexarotene HHSN2612015000240 to: HHSN26100004 POP: 9/18/2017 to 9/17/2019
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,111,543
Award facts
- Opportunity
-
- N01CN4500945 Solicitation number
- Preclinical PREVENT Cancer Program- Toxicology and Pharmacology Testing Award Notice · Posted Sep 26, 2015
- Contract value 100% obligated
- $2,111,543.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$542,120 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $56,577 | |
| Original award | $2,597,086 |
About this award
This is a federal contract award to IIT Research Institute by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The $2,111,543.00 firm fixed price delivery order is for support related to the aerosol development of the drug bexarotene under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) master indefinite delivery/indefinite quantity (IDIQ) contract. IIT Research Institute, the research and technology arm of Illinois Institute of Technology, provides preclinical drug testing services as a prime contractor to federal agencies like the NIH across therapeutic areas including cancer, neurology, and neglected diseases. The contract does not have a set-aside designation. IIT Research Institute has multiple IDIQ contracts with the NIH to support preclinical drug development efforts.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN26100004 worth?
The government has obligated $2,111,543 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201500024I, an indefinite delivery contract, on PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award